Skip to content
OpenCapital
Get started

Evommune EVMN Nutraceuticalsupplements — Revenue

Other product segments

Hemp Derived Products
$6.27K-91.0%

Similar metrics at other companies

HWK
HWKNNutrition — Revenue
$62.78M-4.9%
Natural Grocers by Vitamin Cottage logo
NGVCDietary Supplements — Revenue
$63.99M-3.3%
ITT logo
ITTHealth and Nutrition — Revenue
$89.6M—
Abbott logo
ABTNutritional Products — Net Sales
$2.02B-6.0%
Esperion Therapeutics logo
ESPRProduct sales, net — Total Revenues
$43.4M+24.3%
Phibro Animal Health logo
PAHCNutritional Specialties — Revenue
$46.81M+8.0%

Other financials

Income statement

See full
Revenue$1.6M+3.5%
Gross profit$961.1K+10.9%
Operating income-$682.8K-2,027%
Net income-$7.0M-5,414%
EPS (diluted)-$0.36-1,700%

Balance sheet

See full
Cash & equivalents$1.1M+401%
Total debt$2.0M—
Total equity-$4.5M-3,048%
Total assets$7.2M—

Cash flow

See full
Operating cash flow-$424.6K-341%
CapEx$1.0-99.8%
Free cash flow-$2.7M-4,996%

Valuation

See full
Market cap$848.59M+39.5%
Enterprise value$849.52M—
P/S127.3×—

Profitability

See full
Gross margin53.7%—
Operating margin-30.7%—
Net margin-90.1%—

Returns & leverage

See full
Return on equity275.7%—
Debt / equity1.4×—
Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's nutraceuticalsupplements — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evommune 's nutraceuticalsupplements — revenue?
Evommune (EVMN) reported nutraceuticalsupplements — revenue of $1.64M in Q1 2026.
How has Evommune 's nutraceuticalsupplements — revenue changed year-over-year?
Evommune 's nutraceuticalsupplements — revenue increased by 7.8% year-over-year, from $1.52M to $1.64M.
What does nutraceuticalsupplements — revenue mean?
This metric represents the total gross income generated from the sale of nutraceutical and supplement products within the specified reporting period. It reflects the market demand and commercial performance of the company's non-pharmaceutical health and wellness product line. Tracking this revenue stream helps investors evaluate the contribution of diversified consumer health offerings to the company's overall financial profile.